Contact
searchSearch
HMP Global

The Dermatologist

Expert Insights

  • Peter Lio
    Expert Insights
    Environmental Triggers of Atopic Dermatitis & Seasonal Allergies
    03/05/2026
    Peter Lio, MD, FAAD
    In this interview, Peter Lio, MD, explores how modern environmental exposures—from pollution to lifestyle shifts—are accelerating type 2 inflammation and fueling atopic dermatitis and seasonal allergies in today’s patients.
    In this interview, Peter Lio, MD, explores how modern environmental exposures—from pollution to lifestyle shifts—are accelerating type 2 inflammation and fueling atopic dermatitis and seasonal allergies in today’s patients.
    In this interview, Peter Lio,...
    03/05/2026
    Allergy & Immunology
  • Dr Brett King
    Videos
    Expectations for JAK Inhibitor Treatment of Alopecia Areata
    03/04/2026
    Brett A. King, MD, PhD
    Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
    Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
    Oral JAK inhibitors are...
    03/04/2026
    The Dermatologist
  • Brian Kim, MD, MTR
    Videos
    Type 2 Inflammation and the Biology of Itch in Prurigo Nodularis
    03/02/2026
    Brian Kim, MD, MTR, FAAD
    Chronic itch in prurigo nodularis is increasingly understood as a neuroimmune process driven by type 2 cytokines rather than histamine alone. In this interview, Dr Kim explores how IL-4, IL-13, and IL-31 interact with sensory neurons to...
    Chronic itch in prurigo nodularis is increasingly understood as a neuroimmune process driven by type 2 cytokines rather than histamine alone. In this interview, Dr Kim explores how IL-4, IL-13, and IL-31 interact with sensory neurons to...
    Chronic itch in prurigo...
    03/02/2026
    The Dermatologist
  • Fabrizio Galimberti, MD
    Videos
    Treating Generalized Pustular Psoriasis
    02/28/2026
    Jessica Garlewicz
    Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
    Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
    Generalized pustular psoriasis...
    02/28/2026
    The Dermatologist
  • Blauvelt
    Videos
    Oral IL-23 Therapies in Psoriasis: Addressing Undertreatment, Adherence, and Patient Preference
    02/17/2026
    Riya Gandhi, MA
    Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
    Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
    Dr Andrew Blauvelt discusses how...
    02/17/2026
    The Dermatologist
  • Melissa Piliang
    Videos
    Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
    02/01/2026
    Melissa Piliang, MD
    In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
    In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
    In an insightful conversation...
    02/01/2026
    The Dermatologist
  • Peter Lio
    Clinical Insights
    Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis
    01/20/2026
    Peter Lio, MD, FAAD
    Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
    Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
    Dr Peter Lio discusses how...
    01/20/2026
    Allergy & Immunology
  • Stephen D. Hess, MD, PhD
    Videos
    Electrical Impedance Spectroscopy For Skin Cancer Screening
    01/13/2026
    Stephen D. Hess, MD, PhD
    Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
    Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
    Dr Stephen Hess shares how he...
    01/13/2026
    The Dermatologist
  • melissa Piliang
    Videos
    JAK Inhibitors & Boxed Warnings
    12/17/2025
    Melissa Piliang, MD
    Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
    Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
    Gain expert insight into the...
    12/17/2025
    The Dermatologist
  • Part 3
    Videos
    Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata
    11/03/2025
    Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
    In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
    In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
    In the final installment of this...
    11/03/2025
    The Dermatologist

Featured

Atopic dermatitis
News
Component-Resolved Diagnostics May Enable Precision Allergen Profiling in Atopic Dermatitis
03/19/2026
Jessica Garlewicz
Component-resolved diagnostics may offer a more precise approach to allergen assessment in atopic dermatitis, according to a review examining its potential role in personalized disease management.
Component-resolved diagnostics may offer a more precise approach to allergen assessment in atopic dermatitis, according to a review examining its potential role in personalized disease management.
Component-resolved diagnostics...
03/19/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
Q&A
Sunscreen Filters: What’s New in UVA Protection, Formulations, and Global Options
03/17/2026
Explore the latest advances in sunscreen filter technology, including improved UVA coverage, photostability, and cosmetic formulations that enhance patient adherence. Learn how U.S. regulatory limitations compare with international markets,...
Explore the latest advances in sunscreen filter technology, including improved UVA coverage, photostability, and cosmetic formulations that enhance patient adherence. Learn how U.S. regulatory limitations compare with international markets,...
Explore the latest advances in...
03/17/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
psoriasis
News
Visceral Adiposity Linked to Psoriasis Risk, With Inflammation as Partial Mediator
03/11/2026
Jessica Garlewicz
Higher body roundness index, a measure of visceral adiposity, is associated with increased psoriasis prevalence, and systemic immune activation may partially mediate this relationship.
Higher body roundness index, a measure of visceral adiposity, is associated with increased psoriasis prevalence, and systemic immune activation may partially mediate this relationship.
Higher body roundness index, a...
03/11/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist

From The Issue

Cover Story
More Than Cosmetic: Reframing Hyperpigmentation as a Clinical and Psychosocial Priority
03/09/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Coleen Stern, MA; Riya Gandhi, MA
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the...
03/09/2026
The Dermatologist
Feature Story
Biosimilars in Dermatology: What Clinicians Need to Know in 2026
03/09/2026
Omar Raheel, BA; Jade Bajic, BSc; Ryan Hirsh, BS; Steven R. Feldman, MD, PhD
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions...
03/09/2026
The Dermatologist
Feature Story
Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice
03/09/2026
David Fudman, MD; Riya Gandhi, MA
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David...
03/09/2026
The Dermatologist
Derm Dx
What Is This Persistent Scaly Plaque in the Axilla?
03/09/2026
Aamir N. Hussain, MD, MAPP; Umayr R. Shaikh, MPH; Kabir Al-Tariq, MS; David Terrano, MD, PhD
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a history of hypertension and nonalcoholic fatty liver disease presented with a pruritic rash localized to her right axilla for 2 months.
A 55-year-old woman with a...
03/09/2026
The Dermatologist
HSF-Reviewed Content
From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa
03/09/2026
Mondana Ghias, MD, FAAD
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach,...
03/09/2026
The Dermatologist
Clinical Tips
The “Email Yourself” Reflection Habit
03/09/2026
Benjamin Barankin, MD, FRCPC
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from...
03/09/2026
The Dermatologist
Derm Dx
What Caused These Changes on the Shins?
01/30/2026
Bruh Alem, MD; Aklilu Melaku, MD; Amor Khachemoune, MD, FAAD, FACMS
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history...
01/30/2026
The Dermatologist
Cover Story
Forward Focus: Top Trends in Dermatology for 2026
01/30/2026
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and...
01/30/2026
The Dermatologist
Clinical Tips
Do Not Be Fooled By This Acne Look-Alike
01/30/2026
Benjamin Barankin, MD, FRCPC
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from...
01/30/2026
The Dermatologist
Derm Dx
What Is This Process That Occurs in Hairdressers?
12/09/2025
Kassidy Fishman, BBA; Stephanie Liu, DO, MBA; Robert Adler, BA; Isha Gandhi, BS; Robert Phelps, MD
A 57-year-old man who works as barber presented with a nodule on his dorsal right hand.
A 57-year-old man who works as barber presented with a nodule on his dorsal right hand.
A 57-year-old man who works as...
12/09/2025
The Dermatologist

Multimedia

Peter Lio
Expert Insights
Environmental Triggers of Atopic Dermatitis & Seasonal Allergies
03/05/2026
Peter Lio, MD, FAAD
In this interview, Peter Lio, MD, explores how modern environmental exposures—from pollution to lifestyle shifts—are accelerating type 2 inflammation and fueling atopic dermatitis and seasonal allergies in today’s patients.
In this interview, Peter Lio, MD, explores how modern environmental exposures—from pollution to lifestyle shifts—are accelerating type 2 inflammation and fueling atopic dermatitis and seasonal allergies in today’s patients.
In this interview, Peter Lio,...
03/05/2026
Allergy & Immunology
Dr Brett King
Videos
Expectations for JAK Inhibitor Treatment of Alopecia Areata
03/04/2026
Brett A. King, MD, PhD
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are appropriate for moderate or rapidly progressive alopecia areata, with regrowth often requiring 6 to 12 months and careful tapering, and failure of one agent not predicting failure of another.
Oral JAK inhibitors are...
03/04/2026
The Dermatologist
Brian Kim, MD, MTR
Videos
Type 2 Inflammation and the Biology of Itch in Prurigo Nodularis
03/02/2026
Brian Kim, MD, MTR, FAAD
Chronic itch in prurigo nodularis is increasingly understood as a neuroimmune process driven by type 2 cytokines rather than histamine alone. In this interview, Dr Kim explores how IL-4, IL-13, and IL-31 interact with sensory neurons to...
Chronic itch in prurigo nodularis is increasingly understood as a neuroimmune process driven by type 2 cytokines rather than histamine alone. In this interview, Dr Kim explores how IL-4, IL-13, and IL-31 interact with sensory neurons to...
Chronic itch in prurigo...
03/02/2026
The Dermatologist
Fabrizio Galimberti, MD
Videos
Treating Generalized Pustular Psoriasis
02/28/2026
Jessica Garlewicz
Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
Generalized pustular psoriasis...
02/28/2026
The Dermatologist
Blauvelt
Videos
Oral IL-23 Therapies in Psoriasis: Addressing Undertreatment, Adherence, and Patient Preference
02/17/2026
Riya Gandhi, MA
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how emerging oral IL-23 therapies may address persistent gaps in psoriasis care, including undertreatment and nonadherence.
Dr Andrew Blauvelt discusses how...
02/17/2026
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients.
In an insightful conversation...
02/01/2026
The Dermatologist
Peter Lio
Clinical Insights
Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis
01/20/2026
Peter Lio, MD, FAAD
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how...
01/20/2026
Allergy & Immunology
Stephen D. Hess, MD, PhD
Videos
Electrical Impedance Spectroscopy For Skin Cancer Screening
01/13/2026
Stephen D. Hess, MD, PhD
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he...
01/13/2026
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
Part 3
Videos
Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this...
11/03/2025
The Dermatologist

Partner Reviewed

NEA Approved Features
Supporting the Transition to Self- Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NRS Approved Features
Do Fungi Play a Role in Rosacea?
01/30/2026
Andrew Huff
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may...
01/30/2026
The Dermatologist
NPF Endorsed Features
Position Statement: Routine TB Testing for IL-17 and IL-23 Inhibitors
01/30/2026
Lisa Kuhns, PhD, MD
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical Board/International Psoriasis Council joint position statement concludes that routine latent tuberculosis infection testing is unnecessary for patients with psoriasis who are taking IL-17 or IL-23 inhibitors.
A new NPF Medical...
01/30/2026
The Dermatologist
NAAF-Reviewed Content
Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy
01/30/2026
Brett A. King, MD, PhD
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the treatment landscape for alopecia areata, clinicians face new questions about when to initiate treatment, therapeutic expectations, and management over time.
As JAK inhibitors reshape the...
01/30/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
NAAF-Reviewed Content
Psychosocial Impact of Alopecia Areata in Pediatric Populations
10/06/2025
Riya Gandhi, MA
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health assessment and support into our management of this disease in children and adolescents is imperative to ensure positive quality of life outcomes.
Integrating mental health...
10/06/2025
The Dermatologist
NPF Endorsed Features
Psoriatic Disease and the Domino Effect of Comorbidities
10/06/2025
Lisa Kuhns, PhD, MD
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown that people with psoriasis and psoriatic arthritis face higher rates of serious comorbidities
Research has consistently shown...
10/06/2025
The Dermatologist
NRS Approved Features
New Study Finds Skin Microbiome Differences Between Rosacea and Similar Conditions
10/06/2025
Andrew Huff
The community of microorganisms present on our skin may play an important role in the development of steroid-induced rosacea and perioral dermatitis.
The community of microorganisms present on our skin may play an important role in the development of steroid-induced rosacea and perioral dermatitis.
The community of microorganisms...
10/06/2025
The Dermatologist
Cover Story
Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue
09/08/2025
Justin M. Ko, MD, MBA
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares...
09/08/2025
The Dermatologist
NEA Approved Features
Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care
09/08/2025
Jessica Garlewicz
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association...
09/08/2025
The Dermatologist

News and FDA Alerts

psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

Quizzes and Polls

Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

Professional Development

Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Dr. Adam Friedman and Jaya Manjunath
Podcasts
The Elderderm: Episode 4, Combatting Barriers to Care For Elder Patients
10/16/2024
Adam Friedman, MD
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration are key to a successful medical intervention.
Collaboration and consideration...
10/16/2024
The Dermatologist
The ElderDerm: Episode 3, Shared- Decision Making
Podcasts
The ElderDerm: Episode 3, Shared-Decision Making
05/16/2024
Adam Friedman, MD; Jaya Manjunath
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the...
05/16/2024
The Dermatologist
Aging and Geriatric Evaluation in Dermatology
Podcasts
The ElderDerm: Episode 2, Aging and Geriatric Evaluation in Dermatology
04/22/2024
Adam Friedman, MD; Jaya Manjunath
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm...
04/22/2024
The Dermatologist
ElderDerm
Podcasts
The ElderDerm: Episode 1, Geriatric Dermatology
01/29/2024
Jaya Manjunath; Adam Friedman, MD
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm Podcast, where co-hosts Dr Adam Friedman and Jaya Manjunath discuss what is geriatric dermatology, and why there is a need for this area in training.
Listen to the first ElderDerm...
01/29/2024
The Dermatologist

Conference Coverage

wells
Clinical Insights
Addressing Unmet Needs in Psoriatic Arthritis: Diagnosis, Pathogenesis, and Newer/Emerging Oral Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a...
03/02/2026
The Dermatologist
Blauvelt
Clinical Insights
Transforming Psoriasis Care: Oral IL-23 Therapy and the Next Frontier in Patient-Centered Treatment
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that psoriasis should be approached as a whole-person disease, one that affects mental health and is associated with systemic comorbidities.
Dr Blauvelt emphasized that...
03/02/2026
The Dermatologist
Werth
Clinical Insights
Advances in Dermatomyositis: The Evolving Landscape and Potential Role of Novel Therapies to Improve Disease Outcomes
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dermatomyositis is a systemic autoimmune myopathy with prominent cutaneous features and significant heterogeneity across organ involvement, autoantibody profiles, and disease course.
Dermatomyositis is a systemic autoimmune myopathy with prominent cutaneous features and significant heterogeneity across organ involvement, autoantibody profiles, and disease course.
Dermatomyositis is a systemic...
03/02/2026
The Dermatologist
Gottlieb
Clinical Insights
Reimagining Hidradenitis Suppurativa Care: Early Recognition, Therapeutic Innovation, and Multidisciplinary Care Across the Patient Journey
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
During an expert discussion, speakers emphasized that improving outcomes in HS requires earlier recognition, reduction of diagnostic delay, coordinated referral systems, and integration of medical and surgical management.
During an expert discussion, speakers emphasized that improving outcomes in HS requires earlier recognition, reduction of diagnostic delay, coordinated referral systems, and integration of medical and surgical management.
During an expert discussion,...
03/02/2026
The Dermatologist
Asempa
Clinical Insights
Advancing Inclusive Outcome Measures in Dermatology
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr...
03/02/2026
The Dermatologist
Krueger
Clinical Insights
Advancing Oral Therapies in Psoriasis: Targeted Innovation for Improved Disease Control and Patient Adherence
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr Krueger and Dr Glick, evolving strategies for evaluating and treating moderate-to-severe psoriasis were highlighted, with particular attention to high-impact areas.
At a recent session led by Dr...
03/02/2026
The Dermatologist
Yosipovitch
Clinical Insights
Rapid Neuromodulation and Mast Cell Targeting in Chronic Pruritus
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Yosipovitch emphasized that effective itch management requires directly targeting neuronal signaling pathways and mast cell activation, particularly in itch-dominant diseases such as prurigo nodularis.
Dr Yosipovitch emphasized that effective itch management requires directly targeting neuronal signaling pathways and mast cell activation, particularly in itch-dominant diseases such as prurigo nodularis.
Dr Yosipovitch emphasized that...
03/02/2026
The Dermatologist
Yoo
Clinical Insights
Ultrasound as a Transformative Tool in Dermatology: From Cosmetic Imaging to Hidradenitis Suppurativa Assessment and Emerging Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Yoo and Dr Gottlieb reviewed the principles and applications of handheld ultrasound devices, sonographic assessment of hidradenitis suppurativa, aesthetic procedure guidance, and the expanding landscape of HS therapeutics.
Dr Yoo and Dr Gottlieb reviewed the principles and applications of handheld ultrasound devices, sonographic assessment of hidradenitis suppurativa, aesthetic procedure guidance, and the expanding landscape of HS therapeutics.
Dr Yoo and Dr Gottlieb reviewed...
03/02/2026
The Dermatologist
Dr Heberton
Conference Coverage
Checkpoint Inhibitor Rashes: When to Treat, When to Rechallenge, and When It’s Not the Drug
02/22/2026
Riya Gandhi, MA
A clinical update on cutaneous immune-related adverse events from PD-1/PD-L1 inhibitors, covering lichenoid eruptions, psoriasis, bullous pemphigoid, dupilumab, steroid-sparing strategies, and immune checkpoint inhibitor rechallenge.
A clinical update on cutaneous immune-related adverse events from PD-1/PD-L1 inhibitors, covering lichenoid eruptions, psoriasis, bullous pemphigoid, dupilumab, steroid-sparing strategies, and immune checkpoint inhibitor rechallenge.
A clinical update on cutaneous...
02/22/2026
The Dermatologist
Dr Heberton
Conference Coverage
EGFR Inhibitor Rashes: Prophylaxis, Isotretinoin, and When to Culture
02/22/2026
Riya Gandhi, MA
A clinical update on cutaneous toxicities of epidermal growth factor receptor inhibitors, covering acneiform eruptions, paronychia, staphylococcal superinfection, xerosis, isotretinoin use, and amivantamab-specific toxicities.
A clinical update on cutaneous toxicities of epidermal growth factor receptor inhibitors, covering acneiform eruptions, paronychia, staphylococcal superinfection, xerosis, isotretinoin use, and amivantamab-specific toxicities.
A clinical update on cutaneous...
02/22/2026
The Dermatologist

Popular Articles

Shilpi Khetarpal-2024
Podcasts
Diversifying Dermatologic Care: Unmet Needs & Challenges
03/21/2024
Shilpi Khetarpal, MD, FAAD
In this podcast, Dr Shilpi Khetarpal delve into the challenges and opportunities in providing dermatological care to diverse populations.
In this podcast, Dr Shilpi Khetarpal delve into the challenges and opportunities in providing dermatological care to diverse populations.
In this podcast, Dr Shilpi...
03/21/2024
The Dermatologist
NPF Endorsed Features
What’s New in Psoriasis Research
05/03/2024
Jessica Garlewicz; Riya Gandhi, MA
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this...
05/03/2024
The Dermatologist
Spotlight
A Conversation With Abraham M. Korman, MD
06/06/2024
Benjamin Barankin, MD, FRCPC
Dr Korman is an assistant professor in the department of dermatology at the Ohio State University Wexner Medical Center.
Dr Korman is an assistant professor in the department of dermatology at the Ohio State University Wexner Medical Center.
Dr Korman is an assistant...
06/06/2024
The Dermatologist
psoriasis
News
Diagnosis and Management of Nail Psoriasis and Nail Lichen Planus
06/26/2024
Jessica Garlewicz
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how...
06/26/2024
The Dermatologist
Feature Story
Broadening Definitions: What Constitutes a Natural or Organic Treatment?
09/06/2024
Steven R. Feldman, MD, PhD; Sarah L. Taylor, MD, MPH, BS ; Tom Soker, MD; Matthew L. Melton, MD
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural alternatives to conventional treatments and explains how many conventional dermatology treatments can be considered natural themselves.
This article discusses natural...
09/06/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use